CHI3L1 is overexpressed in different human cancers [48] and CHI3L1 levels in PMF serum are increased, indicating that it is associated with disease progression from early-stage disease (ET, PV) to the myelofibrotic stage [49]. Here, CHI3L1 is linked to essential thrombocythemia.